Company Filing History:
26 out of 4,770 
22 out of 2,405 
1 out of 35 Years Active: 1993-2017
Title: Ann E Weber: A Pioneer in Antiviral and Diabetes Treatment Innovation
Introduction:
Ann E Weber, a resident of Scotch Plains, NJ, has made significant contributions to the field of pharmaceutical research and development. With an impressive portfolio of 49 patents, Weber has successfully brought innovation to the forefront, particularly in the areas of antiviral therapies and diabetes treatment. This article will explore Weber's latest patents, career highlights, notable collaborations, and the impact of her groundbreaking work.
Latest Patents:
Weber's recent patents reflect her commitment to finding effective treatments for viral diseases and diabetes management. One of her notable inventions is the 2'-alkynyl substituted nucleoside derivatives, which offers a potential solution for treating viral infections, specifically hepatitis C virus (HCV) infection. These derivatives exhibit promising pharmacological properties and may pave the way for improved antiviral therapies.
Another significant patent by Weber involves aminotetrahydropyrans as dipeptidyl peptidase-IV (DPP-IV) inhibitors. This innovation holds great potential in the treatment and prevention of diabetes, particularly Type 2 diabetes. By targeting the DPP-IV enzyme, these compounds offer a fresh approach to managing this prevalent metabolic disorder.
Career Highlights:
Weber's career has been largely intertwined with prominent pharmaceutical companies, namely Merck & Company, Inc. and Merck Sharp & Dohme Corporation. Her association with these renowned organizations underscores her expertise and commitment to driving innovation in the healthcare industry.
Collaborations:
Throughout her career, Weber has had the privilege of collaborating with accomplished scientists, further expanding the horizons of her research. Notably, she has worked alongside esteemed individuals such as Tesfaye Biftu and Emma R Parmee. These collaborations have fostered knowledge sharing and interdisciplinary research, leading to breakthroughs in antiviral and diabetes treatment methodologies.
Conclusion:
Ann E Weber's prolific career in pharmaceutical research and development has undeniably made a significant impact on the healthcare industry. With an impressive patent count of 49, Weber's latest inventions reflect her dedication to tackling viral diseases and diabetes. Through her collaborations and groundbreaking work, she continues to push the boundaries of innovation, offering hope for improved therapeutic interventions in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.